Biobot Surgical Pte Ltd was incorporated in 2007 in Singapore, and became a member of ZIG Ventures since 2013.
To ensure success, a team of talents has been put together in the areas of robotic design and technology, medical image processing, software development and clinical application.
To date, the iSR’obot Mona Lisa has obtained key regulatory approvals, including Europe (CE mark), U.S.A (US FDA), Australia (TGA) and Singapore (HSA) and is being used in some of the most prestigious hospitals around the world.
Striving to become the gold standard in diagnosis and prognosis of prostate cancer, the Mona Lisa’s development has been a process of evolution and is the latest in our state of the art new generation designs.
To ensure success, a team of talents has been put together in the areas of robotic design and technology, medical image processing, software development and clinical application.
To date, the iSR’obot Mona Lisa has obtained key regulatory approvals, including Europe (CE mark), U.S.A (US FDA), Australia (TGA) and Singapore (HSA) and is being used in some of the most prestigious hospitals around the world.
Striving to become the gold standard in diagnosis and prognosis of prostate cancer, the Mona Lisa’s development has been a process of evolution and is the latest in our state of the art new generation designs.
Location: Singapore
Employees: 11-50
Phone: +65 6351 1868
Total raised: $15.5M
Founded date: 2007
Funding Rounds 1
| Date | Series | Amount | Investors |
| 07.07.2026 | - | $15.5M | ClavystBio |
Mentions in press and media 7
| Date | Title | Description |
| 07.07.2026 | Biobot Surgical secures $15 M to bring Robotic Prostate Cancer platform to the U.S. | In its most recent funding round, which was led by ClavystBio in collaboration with ZIG Ventures, Biobot Surgical, a Singapore-based medical technology startup creating robotic-assisted systems for prostate cancer diagnostics and treatment,... |
| 30.06.2026 | Deals in brief: Airwallex raises Series H funding, Igloo acquires Eazy Digital, nine China investments, and more | Airwallex raises USD 320 million in Series H funding Airwallex, a global payments and financial platform, said it has raised USD 320 million in Series H funding, lifting its valuation to USD 11 billion from USD 8 billion in December 2025. T... |
| 29.06.2026 | Singapore's Biobot Surgical raises $15.5m in funding led by ClavystBio | - |
| 11.03.2022 | Biobot Surgical signs MOU with BEBIG Medical to collaborate on a robotic-guided prostate brachytherapy solution | SINGAPORE, March 11, 2022 /PRNewswire/ -- Biobot Surgical, a robotic-assisted percutaneous surgical systems company, is delighted to announce a MOU with BEBIG Medical, a global provider of radiotherapy products and a brachytherapy leader ba... |
| 05.03.2022 | New Robotic Assisted Transperineal Needle-Guidance System for Prostate Biopsy and Cancer Ablations Received U.S FDA 510(k) Clearance | SINGAPORE, March 5, 2022 /PRNewswire/ -- Biobot Surgical is excited to announce U.S. FDA 510(k) clearance of the iSR'obot Mona Lisa 2.0. The new robotic assisted transperineal needle-guidance system allows urologists to plan and position a ... |
| - | Biobot Surgical Pte Ltd | “Biobot, Biobot Surgical, Robotic accuracy, Prostate disease management, Mona Lisa robot, Mona Lisa [DX], Mona Lisa 2.0 [TX]” |
| - | Biobot Surgical Pte Ltd | “The Biobot iSR'obot Mona Lisa is a robotic transperineal prostate biopsy system with MRI-ultrasound fusion capability. Designed with both physician and patient in mind, the system enables physicians to perform biopsy with precision and eas... |